Benefits of Neoadjuvant Chemoimmunotherapy Confirmed in Early NSCLC
-
Evolving Technology in Clinical Practice: Using Artificial Intelligence to Your AdvantageAI has the potential to improve clinical practice both by advancing translational therapeutic research and by improving diagnosis and treatment practices.
-
Metastatic Breast Cancer Cases Underreported, Patients Not Receiving Optimal CareExperts have highlighted the need to improve data collection for metastatic breast cancer, end the stigma surrounding the disease, and improve patient outcomes via equitable access to care, individualized treatment, multidisciplinary management, and use of evidence-based guidelines.
-
ACA Plans Are Being Switched Without Enrollees’ OKInsurance agents can access a policyholder’s coverage through the federal exchange or its direct enrollment platforms using only a person’s name, date of birth, and state.
-
New Guidelines for Radiotherapy Use in LA-NSCLCThe American Radium Society has released guidelines for radiotherapy in patients with locally advanced non-small cell lung cancer.
-
Does Fracking Cause Cancer?There are only a few studies investigating whether fracking may cause cancer, so more research is needed to draw a definitive conclusion, said Nicole Deziel, PhD.
Clinical Tools
Powered by
Powered by
Drug Look-up
Select a category
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancers
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic Cancers
- Head and neck cancer
- Kaposi's sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
- Solid tumors
Drug Comparison Charts
Select a category
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancers
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic Cancers
- Head and neck cancer
- Kaposi's sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
- Solid tumors
Calculators
MORE CLINICAL TOOLS
Select a category
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancers
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic Cancers
- Head and neck cancer
- Kaposi's sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
- Solid tumors
More From
EXPLORE OUR NETWORKRitux 3 Regimen Provides Patients With Pemphigus With Sustained Remission
Efficacy of a Co-Located Bridging Recovery Initiative for Opioid Use Disorder
US Oncologists, Hematologists Receive More Industry Payments Than Their Peers
FDA Withdraws Approval of Pepaxto for Multiple Myeloma
PIDS Updates Guidance on COVID-19 Management in Children, Adolescents
- Bladder Cancer
- Breast Cancer
- Central Nervous System Cancers
- Endocrine Cancers
- Gastrointestinal Cancers
- General Medicine
- General Oncology
- Genitourinary Cancers
- Gynecologic Cancers
- Head and Neck Cancers
- Hematologic Cancers
- Leukemia
- Lung Cancer
- Lymphoma
- Myeloma
- Pediatric Cancer
- Prostate Cancer
- Renal Cell Carcinoma
- Sarcomas
- Skin Cancers